This inventor holds 42 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 5 EPO patents, primarily in Molecular Biology. Top assignees: Human Genome Sciences, Inc., J. Craig Venter Institute, Novartis Ag. Active years: 1996-2019.
Location History:
- North Potomac, MD (US) (1999)
- Gueenstown, MD (US) (1996 - 2002)
- Queenstown, MD (US) (1996 - 2003)
- Potomac, MD (US) (2002 - 2016)
- Clarksville, MD (US) (2011 - 2019)
Company Filing History:
13 out of 676 
11 out of 20 
7 out of 3,974 
Years Active: 1996-2019
Areas of Expertise:
Title: The Innovations of Claire M. Fraser: Pioneering Research in Streptococcus Proteins
Introduction: Claire M. Fraser is an accomplished inventor based in Queenstown, Maryland, known for her significant contributions to the field of molecular biology. With a remarkable portfolio of 42 patents, Fraser has made groundbreaking advancements in the understanding of nucleic acids and proteins, particularly from Streptococcus groups A and B.
Latest Patents: Among her most recent innovations, Fraser has developed technologies that provide valuable proteins from both group A and group B Streptococcus. These inventions include detailed amino acid and nucleotide sequences, showcasing how these proteins serve as useful antigens for vaccines, immunogenic compositions, and diagnostics. Furthermore, this research highlights the potential of these proteins as crucial targets for antibiotic development.
Career Highlights: Claire M. Fraser's professional journey has seen her collaborate with prestigious institutions, such as Human Genome Sciences, Inc. and the J. Craig Venter Institute. Her work has not only advanced scientific knowledge but has also paved the way for new medical advancements that have the potential to improve public health outcomes.
Collaborations: Throughout her career, Fraser has worked alongside notable colleagues, including Maria Scarselli and Guido Grandi. These collaborations have played a crucial role in her research and patent development, fostering an environment of innovation and discovery.
Conclusion: Claire M. Fraser stands out as a leading inventor whose work has had a profound impact on biomedical research. Her patents in the area of Streptococcus proteins underscore her commitment to developing new diagnostic and therapeutic strategies. As the landscape of science continues to evolve, Fraser's contributions will remain significant in the fight against infectious diseases.